Iracet™

Levetiracetam
Antiepileptic (CNS Preparations)

Indication:

Iracet^TM (Levetiracetam) is indicated as an adjunctive therapy for Partial Onset Seizures, Myoclonic Seizures in Patients with Juvenile Myoclonic Epilepsy, Primary Generalized Tonic-Clonic Seizures

Dosage & Administration:

Treatment should be initiated with a daily dose of 1000 mg/day, given as twice-daily dosing (500 mg twice daily). Additional dosing increments may be given (1000 mg/day additional every 2 weeks) to a maximum recommended daily dose of 3000 mg.
Use in Pediatric Patients

Age/weight	Initial dose (Daily)	Incremental dose (Daily)
1 Month To < 6 Months	7 mg/kg twice daily	21 mg/kg twice daily
6 Months To < 4 Years	10 mg/kg twice daily	25 mg/kg twice daily
4 Years To < 16 Years	10 mg/kg twice daily	30 mg/kg twice daily

Preparation:

Iracet^TM 250 Tablet: Each box contains 20 tablets in blister pack.
Iracet^TM 500 Tablet: Each box contains 10 tablets in blister pack.
Iracet^TM 500 XR Tablet: Each box contains 12 tablets in blister pack.
Iracet^TM Injection: Each box contains 6 ampoules in blister pack.
Iracet^TM Oral solution: Each PET bottle contains 50 ml oral solution.